Trial Profile

Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Patients With Essential Hypertension.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 08 Dec 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bisoprolol (Primary) ; Atenolol
Indications Essential hypertension
Focus Therapeutic Use
Sponsors Merck KGaA

Most Recent Events

20 Aug 2012 Actual patient number changed from 180 to 177 as reported by ClinicalTrials.gov.
20 Aug 2012 Actual initiation date changed from Dec 2010 to Nov 2010 as reported by ClinicalTrials.gov.
20 Aug 2012 Actual end date Feb 2012 added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com